Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 2—February 2007

Research

Meningococcal Disease in South Africa, 1999–2002

Garry B. Coulson*, Meningeal Disease Surveillance in South AfricaComments to Author , Mignon du Plessis*, Anthony M. Smith*, Linda de Gouveia*, Keith P. Klugman*†, Anne von Gottberg*Comments to Author , and for the Group for EntericRespiratoryGERMS-SA
Author affiliations: *National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa; †Emory University, Atlanta, Georgia, USA;

Main Article

Figure 4

Annual age-specific incidence rates for confirmed serogroup A, B, and Y meningococcal disease in South Africa, as reported from August 2001 through July 2002.

Figure 4. Annual age-specific incidence rates for confirmed serogroup A, B, and Y meningococcal disease in South Africa, as reported from August 2001 through July 2002.

Main Article

1GERMS-SA: Sandeep Vasaikar (Eastern Cape); Nolan Janse van Rensberg, Peter Smith (Free State); Khatija Ahmed, Heather Crewe-Brown, Mike Dove, Charles Feldman, Alan Karstaedt, Olga Perovic, Pyu-Pyu Sein, Ruth Lekalakala (Gauteng); Wim Sturm (KwaZulu Natal); Ken Hamese (Limpopo); Keith Bauer (Mpumalanga); Denise Roditi, Rena Hoffmann, Lynne Liebowitz, John Simpson, Andrew Whitelaw (Western Cape); Adrian Brink (AMPATH); Claire Heney (Lancet); Martinus Senekal (PathCare).

TOP